Biosimilar Testing and Development Services Market to Hold $7.8 Billion, by 2032 with 12.1% CAGR: Allied Market Research
The global biosimilar testing and development services industry is transforming due to factors such as a surge in R&D investments on biosimilar testing, patent expiration of original drugs, and rise in demand for biosimilar products PORTLAND, Ore., April 29, 2024 /PRNewswire/ — Allied Mark
Basware’s E-invoicing Platform and Carbon Footprint Tracker Helps Customers Slash Paper Invoices by 80%
Basware releases sustainability agenda to future-proof financial accounting CHARLOTTE, N.C. and HELSINKI, April 29, 2024 /PRNewswire/ — Basware, a global leader in AP automation and invoice processing, has released its first Sustainability Report, outlining how it is helping customers reduce t
Hurom Takes Global Action to Protect Juicer Patents
Protecting Proprietary Technologies and Fostering a Healthy Global Ecosystem SEOUL, South Korea, April 29, 2024 /PRNewswire/ — Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its pr
Sayari Partners with GAN Integrity to Combat Corruption and Modern Slavery in Supply Chains
Sayari and GAN Integrity’s partnership will help companies comply with emerging regulations, including the Corporate Sustainability Due Diligence Directive (CSDDD) WASHINGTON, April 29, 2024 /PRNewswire/ — Sayari, the leading counterparty and supply chain risk intelligence provider, toda
Benefits gained via regional coordination
BEIJING, April 29, 2024 /PRNewswire/ — This is a report from China Daily: Aiming to become a hub for the coordinated development of the Beijing-Tianjin-Hebei region and bolster high-quality development of Xiong’an New Area, North China’s Hebei province is focusing on creating a re
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
LONDON, April 29, 2024 /PRNewswire/ — Huma Therapeutics (“Huma”), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion
2024 ‘Belt and Road’ Creativity and Sustainable Development Seminar Held in Beijing
BEIJING, April 29, 2024 /PRNewswire/ — A news report from CRI Online: On April 26, the 2024 “Belt and Road” Creative and Sustainable Development Seminar, co-hosted by the International Center for Creativity and Sustainable Development (ICCSD) and the School of International and Pub
TDi Sustainability Launches ‘Material Change for Renewables’ Report to Drive and Inform Responsible Sourcing in the Clean Energy Transition
CHELTENHAM, England, April 29, 2024 /PRNewswire/ — TDi Sustainability, a leading authority in supply chain compliance, has released a new report addressing the critical challenges and considerations surrounding responsible sourcing in the clean energy transition. Material Change for Renewa
Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI
STOCKHOLM, April 29, 2024 /PRNewswire/ — Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + L
Mirae Asset Celebrates Inclusion of Global X Hang Seng High Dividend Yield ETF in Stock Connect Scheme
HONG KONG, April 29, 2024 /PRNewswire/ — Mirae Asset Global Investments (Hong Kong) Limited, (the “Firm” or “Mirae Asset”) is pleased to announce that the Global X Hang Seng High Dividend Yield ETF (3110) will be included in the Stock Connect Scheme (the “Scheme&#
